HomeAKTS • NASDAQ
add
Aktis Oncology Inc
Previous close
$18.00
Day range
$19.33 - $29.16
Market cap
3.54B USD
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 933.00K | — |
Operating expense | 3.96M | — |
Net income | -12.06M | — |
Net profit margin | -1.29K | — |
Earnings per share | — | — |
EBITDA | -15.19M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 297.17M | — |
Total assets | 326.18M | — |
Total liabilities | 80.58M | — |
Total equity | 245.61M | — |
Shares outstanding | 781.00K | — |
Price to book | -0.16 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -12.06M | — |
Cash from operations | -12.80M | — |
Cash from investing | -172.88M | — |
Cash from financing | -1.80M | — |
Net change in cash | -187.48M | — |
Free cash flow | — | — |
About
Founded
2020
Website
Employees
76
